Clinical trials
Phase 3 Insulin Resistance trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gan and Lee Pharmaceuticals, USA | 2 |
| Biopolis S.L. | 1 |
| Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 4 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Obesity | 2 |
| Body Weight | 1 |
| Cardiovascular Diseases | 1 |
| Erectile Dysfunction | 1 |
| Hypogonadism | 1 |
| Inflammation | 1 |
| Weight Loss | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.